What is the recommended antibiotic treatment for a patient with Enterobacter faecalis infection, considering potential impaired renal function, history of bleeding disorders, and gastrointestinal disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Enterococcus faecalis Infection

Critical First Step: Confirm Species Identity

You are likely dealing with Enterococcus faecalis (not "Enterobacter faecalis" which does not exist as a species). This distinction is crucial because treatment differs significantly between E. faecalis and E. faecium. 1

First-Line Treatment Recommendations

Ampicillin or amoxicillin remains the drug of choice for E. faecalis infections, even in patients with renal impairment, as high urinary concentrations can overcome elevated MICs. 1

For Hospitalized Patients Requiring IV Therapy:

  • Ampicillin 2 g IV every 4-6 hours (18-30 g daily in divided doses) 2, 1
  • Alternative: Amoxicillin 500 mg IV every 8 hours 1

For Uncomplicated Urinary Tract Infections (Oral):

  • Amoxicillin 500 mg orally every 8 hours for 7 days (first-line, 88.1% clinical cure rate) 1
  • Alternative: Ampicillin 500 mg orally every 8 hours for 7 days 1

Alternative Agents for Specific Clinical Scenarios

For Penicillin Allergy or Beta-Lactam Intolerance:

  • Nitrofurantoin 100 mg orally every 6 hours for 7 days for uncomplicated UTI only (resistance <6%) 1
  • Fosfomycin 3 g orally as single dose for uncomplicated UTI (FDA-approved specifically for E. faecalis) 1

Critical caveat: Nitrofurantoin is contraindicated if creatinine clearance <60 mL/min, as urinary concentrations become inadequate. 1 This is particularly important given your patient's potential renal impairment.

For Serious/Invasive Infections (Bacteremia, Endocarditis, Intra-abdominal):

For endocarditis or bacteremia, dual therapy is required:

  • Ampicillin 2 g IV every 4 hours PLUS Gentamicin 3 mg/kg/day IV in 3 divided doses for 4-6 weeks (if gentamicin-susceptible) 2
  • Alternative dual beta-lactam: Ampicillin 2 g IV every 4 hours PLUS Ceftriaxone 2 g IV every 12 hours for 6 weeks 2
  • Emerging alternative: Meropenem 2 g IV every 8 hours PLUS Ceftaroline 600 mg IV every 8 hours (demonstrated equivalent activity to ampicillin/ceftriaxone in pharmacodynamic models) 3

For vancomycin-susceptible, penicillin-resistant strains (rare in E. faecalis):

  • Vancomycin 30 mg/kg/day IV in 2 divided doses PLUS Gentamicin 3 mg/kg/day IV in 3 divided doses for 6 weeks 2

For Healthcare-Associated Intra-abdominal Infections:

If E. faecalis is suspected as part of polymicrobial infection:

  • Piperacillin-tazobactam 4.5 g IV every 6 hours (has activity against ampicillin-susceptible enterococci) 2
  • Imipenem-cilastatin 1 g IV every 8 hours (active against ampicillin-susceptible enterococci) 2, 4
  • Meropenem 1 g IV every 8 hours PLUS Ampicillin 2 g IV every 6 hours for high-risk patients 2

Special Considerations for Your Patient's Comorbidities

Renal Impairment:

  • Ampicillin/amoxicillin remains preferred as high urinary concentrations overcome resistance even with elevated MICs 1
  • Avoid nitrofurantoin if CrCl <60 mL/min 1
  • Gentamicin requires dose adjustment and therapeutic drug monitoring (target peak 20-35 μg/mL, trough <10 μg/mL) 2, 5
  • Meropenem and imipenem require dose reduction based on creatinine clearance 6, 7

Bleeding Disorders:

  • Avoid IM injections of gentamicin; use IV route only 5
  • Carbapenems (imipenem, meropenem) have not been associated with coagulation disorders, unlike some other beta-lactams 6

Gastrointestinal Disease:

  • Avoid nitrofurantoin if significant GI disease present, as it can cause nausea and GI upset 1
  • Consider IV therapy if oral absorption is compromised 1

Critical Pitfalls to Avoid

  1. Do not use cephalosporins as monotherapy - E. faecalis has intrinsic resistance to cephalosporins when used alone 2

  2. Do not use fluoroquinolones - resistance rates are 46-47% for ciprofloxacin/levofloxacin 1

  3. Do not use nitrofurantoin for:

    • Complicated UTI or pyelonephritis (poor tissue penetration) 1
    • Bacteremia or systemic infections 1
    • Patients with CrCl <60 mL/min 1
  4. Always obtain susceptibility testing before finalizing therapy, even for "pansensitive" strains, as resistance patterns vary by institution 1

  5. Differentiate colonization from infection - asymptomatic bacteriuria with E. faecalis does not routinely require treatment 1, 8

  6. For serious infections, do not use ampicillin monotherapy - combination therapy with gentamicin or ceftriaxone is required for synergy 2

Treatment Duration

  • Uncomplicated UTI: 7 days 1
  • Complicated UTI/pyelonephritis: 10-14 days (based on clinical response) 1
  • Bacteremia: 2-4 weeks (depending on source control) 2
  • Endocarditis: 4-6 weeks (native valve with symptoms <3 months may use 4 weeks; prosthetic valve requires 6 weeks) 2

References

Guideline

Treatment for Enterococcus faecalis in Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Meropenem: evaluation of a new generation carbapenem.

International journal of antimicrobial agents, 1997

Guideline

Antibiotic Use and Enterococcus faecalis Colonization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.